logo

ACA

Arcosa·NYSE
--
--(--)
--
--(--)
5.26 / 10
Netural

Fundamental analysis rates Arcosa neutral at 5.3/10. Asset‑MV and Revenue‑MV rank high, boosting the score, while Profit‑MV and Net‑income‑Revenue lag. Cash‑MV and ROA are solid, margins modest, and earnings growth is strong but low‑quality, yielding an overall moderate stance.

Fundamental(5.26)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value0.22
Score3/3
Weight18.80%
1M Return16.59%
ROA (%)
Value4.21
Score2/3
Weight6.61%
1M Return6.95%
Profit-MV
Value0.62
Score1/3
Weight7.33%
1M Return8.66%
Net income-Revenue
Value-0.51
Score0/3
Weight8.48%
1M Return8.77%
Basic earnings per share (YoY growth rate %)
Value121.35
Score0/3
Weight0.08%
1M Return0.11%
Net cash flow from operating activities / Total liabilities (%)
Value0.15
Score0/3
Weight1.24%
1M Return1.72%
Annualized net profit margin on total assets (%)
Value4.21
Score2/3
Weight6.61%
1M Return6.95%
Asset-MV
Value-0.49
Score3/3
Weight29.09%
1M Return22.10%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value122.41
Score0/3
Weight0.11%
1M Return0.16%
Cash-MV
Value-0.11
Score3/3
Weight21.64%
1M Return19.43%
Is ACA undervalued or overvalued?
  • ACA scores 5.26/10 on fundamentals and holds a Fair valuation at present. Backed by its 8.22% ROE, 7.23% net margin, 25.66 P/E ratio, 2.02 P/B ratio, and 121.35% earnings growth, these metrics solidify its Netural investment rating.